Abstract
Pulmonary function tests are commonly used within research to characterize disease patterns of obstructive airway diseases, and to describe lung growth and development. 20 out of 52 European birth cohorts within the ENRIECOand GA2LEN-networks reported a total of 80 investigation time-points using pulmonary function assessments. Information on published results and guidelines used were complemented through publicly available data and peer reviewed journals. Only 4 cohorts used the same test for at least 3 time-points during their follow-up. The tests were used to classify airway obstruction, bronchodilator response and bronchial hyperresponsiveness. Related methods assessed airway inflammation non-invasively. International guidelines, used in clinical practice, (American Thoracic Society/ European Respiratory Society) should be considered and referred to whenever possible to improve comparability. A consensus on when and how pulmonary function tests are beneficial in population based research, assessing lung growth or asthma subtypes, is needed.
Keywords: Asthma, exhaled nitric oxide, guidelines, lung development, spirometry.
Current Respiratory Medicine Reviews
Title:Pulmonary Function Tests in European Birth Cohorts
Volume: 9 Issue: 1
Author(s): Linus Grabenhenrich, Cynthia Hohmann, Remy Slama, Joachim Heinrich, Magnus Wickman, Carel Thijs, Kai-Hakon Carlsen, Karin Lodrup Carlsen, Susanne Lau and Thomas Keil
Affiliation:
Keywords: Asthma, exhaled nitric oxide, guidelines, lung development, spirometry.
Abstract: Pulmonary function tests are commonly used within research to characterize disease patterns of obstructive airway diseases, and to describe lung growth and development. 20 out of 52 European birth cohorts within the ENRIECOand GA2LEN-networks reported a total of 80 investigation time-points using pulmonary function assessments. Information on published results and guidelines used were complemented through publicly available data and peer reviewed journals. Only 4 cohorts used the same test for at least 3 time-points during their follow-up. The tests were used to classify airway obstruction, bronchodilator response and bronchial hyperresponsiveness. Related methods assessed airway inflammation non-invasively. International guidelines, used in clinical practice, (American Thoracic Society/ European Respiratory Society) should be considered and referred to whenever possible to improve comparability. A consensus on when and how pulmonary function tests are beneficial in population based research, assessing lung growth or asthma subtypes, is needed.
Export Options
About this article
Cite this article as:
Grabenhenrich Linus, Hohmann Cynthia, Slama Remy, Heinrich Joachim, Wickman Magnus, Thijs Carel, Carlsen Kai-Hakon, Carlsen Karin Lodrup, Lau Susanne and Keil Thomas, Pulmonary Function Tests in European Birth Cohorts, Current Respiratory Medicine Reviews 2013; 9 (1) . https://dx.doi.org/10.2174/1573398X11309010002
DOI https://dx.doi.org/10.2174/1573398X11309010002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Epidemiological Evidence on Short-Term Effects of Environmental Factors on Respiratory Problems in Children
Current Respiratory Medicine Reviews Subject Index To Volume-3
Letters in Drug Design & Discovery TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
Current Drug Targets Chemokines in Allergy
Current Drug Targets - Inflammation & Allergy Biochanin A Ameliorates Ovalbumin-induced Airway Inflammation through Peroxisome Proliferator-Activated Receptor-Gamma in a Mouse Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Latest Updates in Dengue Fever Therapeutics: Natural, Marine and Synthetic Drugs
Current Medicinal Chemistry Functionally Engineered Nanosized Particles in Pharmaceutics: Improved Oral Delivery of Poorly Water-soluble Drugs
Current Pharmaceutical Design Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets Recent Advances and Perceptions in Studies of Heterodimerization between G Protein-Coupled Receptors
Protein & Peptide Letters Treatment with Paracetamol is not Associated with Increased Airway Sensitivity and Risk of Asthma in Rats
Current Drug Safety Past, Present and Future of Electroanalytical Sensor for Aspirin, Ibuprofen and Paracetamol Detection
Current Pharmaceutical Analysis Neuroimmune Interactions and Psychologycal Stress Induced by Cohabitation with a Sick Partner: A Review
Current Pharmaceutical Design Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
Current Drug Delivery Antiplasmodial and Cytotoxic Activities of two <i>Euphorbiaceae</i> Family Plants, <i>Euphorbia hirta</i> and <i>Euphorbia thymifolia</i>
Current Bioactive Compounds Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Role of Oxygen Radicals on Bronchial Asthma
Current Drug Targets - Inflammation & Allergy Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism The Role of Platelets in Bone Remodeling
Inflammation & Allergy - Drug Targets (Discontinued) Is Helicobacter pylori Always a "Bad Guy"?
Current Pharmaceutical Design High Yield Immobilization and Stabilization of Oxidoreductases Using Magnetic Nanosupports and Their Potential Applications: An Update
Current Catalysis